Rising Cancer Rates Fuel Growth In Transfection Reagents And Equipment Market: A Key Factor Shaping the Future of the Transfection Reagents And Equipment Market in 2025

What combination of drivers is leading to accelerated growth in the transfection reagents and equipment market?
The global increase in cancer patients is projected to fuel the expansion of the transfection reagents and equipment market. Cancer is a disease typified by abnormal and uncontrolled cell growth. Transfection reagents, which are often employed in cancer research, facilitate the introduction of foreign genetic substances, such as plasmid DNA or RNA molecules. This enables researchers to delve into many cancer-related areas such as gene silencing, gene expression studies, target validation, and drug screening. As an example, the American Cancer Society, a non-profit organization based in the US, recorded 20 million new cases of cancer and 9.7 million fatalities in 2022. Therefore, it's clear that the escalating count of worldwide cancer patients is driving the expansion of the transfection reagents and equipment market.

Get Your Transfection Reagents And Equipment Market Report Here:
https://www.thebusinessresearchcompany.com/report/transfection-reagents-and-equipment-global-market-report

What is the projected compound annual growth rate (CAGR) of the transfection reagents and equipment market from 2025 to 2034, and what factors influence it?
The market size for transfection reagents and equipment has experienced swift expansion in the past few years. It is projected to increase from $1.58 billion in 2024 to $1.75 billion in 2025, indicating a compound annual growth rate (CAGR) of 10.7%. The surge during the historic period is credited to the demand for biomedical research, pharmaceutical development, the expansion of biotechnology applications, academic and research institutions, and advancements in genetic engineering.

In the coming years, the transfection reagents and equipment market is anticipated to experience accelerated growth, projected to reach a valuation of $2.69 billion by 2029, with a compound annual growth rate (CAGR) of 11.3%. This projected growth within the forecast period can be credited to the progress in gene therapy, amplified needs for bioproduction, the advent of cell-based therapies, personalized medicine research & development, as well as worldwide collaborations. The projected trends for this period involve emphasis on primary cell transfection, transition towards electroporation methods, the incorporation of nanotechnology in transfection, escalating demand for animal-free transfection reagents, and the surge of automated, high-throughput transfection systems.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10780&type=smp

How are the latest trends influencing the growth of the transfection reagents and equipment market?
Advancements in product development is a notable trend emerging in the transfection reagents and equipment industry. Companies leading in this area are striving to introduce innovative offerings to maintain their market presence. For example, in September 2022, Polyplus-Transfection SA, a French biotech firm, unveiled its in vivo-jetRNA+ transfection reagent aimed at delivering mRNA in vivo using a prepackaged liposome blend. This groundbreaking solution is an effective and scalable gene delivery mechanism capable of transporting mRNA to a variety of cells and tissues. Besides being safe and well-tolerated, the reagent presents valuable prospects for the generation of new genetical treatments. The plug-and-play design eliminates the need for formulation steps, and the unvarying liposome size permits a range of low to high mRNA concentrations over time. Its applications span across preventative vaccinations, mRNA therapies such as cancer treatment, rare diseases and more, as well as gene modification.

What are the major segments of the transfection reagents and equipment market and their role in driving growth?
The transfection reagents and equipment market covered in this report is segmented -

1) By Products: Instruments, Reagent And Kits
2) By Types Of Molecule: Plasmid DNA, DNA Oligonucleotides, Small Interfering RNA (SiRNA), Proteins, Ribonucleoprotein Complexes (RNPs), Other Molecules
3) By Organism: Bacteria, Mammalian Cells, Fungi, Plants, Virus
4) By End User: Biopharma, Contract Research Organizations (CROs), Contract Manufacturing Organizations (CMOs) And Contract Development And Manufacturing Organizations (CDMOs), Academia, Hospitals, Clinical Labs, Other End Users

Subsegments:
1) By Instruments: Electroporation Systems, Microinjection Systems, Particle Bombardment Systems, Other Instruments
2) By Reagent And Kits: Lipid-Based Transfection Reagents, Polymer-Based Transfection Reagents, Protein-Based Transfection Reagents, Nucleic Acid Delivery Kits, Other Reagents And Kits

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10780

Which regions are key players in the growth of the transfection reagents and equipment market?
North America was the largest region in the transfection reagents and equipment market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the transfection reagents and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Who are the key firms paving the way for growth in the transfection reagents and equipment market?
Major companies operating in the transfection reagents and equipment market include Thermo Fisher Scientific Inc., Promega Corporation, Qiagen N.V., Bio-Rad Laboratories Inc., Maxcyte Inc., Lonza Group Ltd., Merck KGaA, Mirus Bio LLC, OriGene Technologies Inc., PromoCell GmbH, PerkinElmer Inc., Agilent Technologies Inc., Altogen Biosystems, Applied Biological Materials Inc., Bex Co. Ltd., Sartorius AG, Takara Bio Inc., Tecan Trading AG, Polyplus-transfection SA, Sigma-Aldrich Corporation, Hoffmann-La Roche Ltd., Transfection Technologies Inc., Viromer, ABM Inc., Bio-Techne Corporation, Biotium Inc., Cell Applications Inc., chemicell GmbH, Genlantis, Biontex Laboratories GmbH, Boca Scientific Inc., Jena Bioscience GmbH

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=10780&type=smp

What Is Covered In The Transfection Reagents And Equipment Global Market Report?

• Market Size Forecast: Examine the transfection reagents and equipment market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the transfection reagents and equipment market for a structured understanding.
• Key Players Overview: Analyze major players in the transfection reagents and equipment market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the transfection reagents and equipment market.
• Segment Contributions: Evaluate how different segments drive overall growth in the transfection reagents and equipment market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the transfection reagents and equipment market.
• Industry Challenges: Identify potential risks and obstacles affecting the transfection reagents and equipment market.
• Competitive Landscape: Review strategic developments in the transfection reagents and equipment market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.